
Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare Disease With No Approved Drugs
The journey of rare disease patients and their families can be a long one marked by misdiagnoses, and so it is for those who have the ultra-rare disorder with the abbreviated name PMM2-CDG. This enzyme deficiency leads to muscle problems and developmental …